Factor V Leiden mutation: a contributory factor for cerebral palsy?

被引:14
|
作者
Reid, S
Halliday, J
Ditchfield, M
Ekert, H
Byron, K
Glynn, A
Petrou, V
Reddihough, D
机构
[1] Royal Childrens Hosp, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
来源
关键词
D O I
10.1017/S0012162206000053
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Fifty-seven children with cerebral palsy (CP) and imaging evidence of vascular thrombosis (study group) and 167 children with CP and other imaging finds (control group) were selected. Sixty-one per cent of the study group were male and 53 (93%) had spastic hemiplegia compared with the control group, of whom 55% were male and 54 (32%) had a diagnosis of spastic hemiplegia. Mean age was 5 years 11 months (SD 5y 1mo) for the study group and 7 years 7 months (SD 4y 7mo) for the control group. Blood spots on Guthrie cards or buccal swabs were used to test both groups and their mothers for the factor V Leiden (fVL) mutation, which predisposes carriers to thrombophilia. Mothers were interviewed to gather antenatal, perinatal, demographic, and socio-economic data. The frequency of the fVL mutation in children with evidence of vascular thrombosis and their mothers was not statistically different from the frequency in children with CP with other imaging findings and their mothers. The frequency of the fVL mutation was significantly higher than the expected population frequency of 4% in the study group (10.5%, p=0.012) and in mothers of the control group (7.2%, p=0.036).
引用
收藏
页码:14 / 19
页数:6
相关论文
共 50 条
  • [21] Factor V Leiden as a cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis?
    Sébire, G
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 426 - 426
  • [22] World distribution of factor V Leiden mutation
    deMaat, MPM
    Kluft, C
    Jespersen, J
    Gram, J
    LANCET, 1996, 347 (8993): : 58 - 58
  • [23] Factor V Leiden mutation and Japanese NIDDM
    M. Odawara
    K. Yamashita
    Diabetologia, 1997, 40 : 1363 - 1364
  • [24] Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice
    Bruggemann, Lois W.
    Schoenmakers, Saskia H. H. F.
    Groot, Angelique P.
    Reitsma, Pieter H.
    Spek, Arnold
    CRITICAL CARE MEDICINE, 2006, 34 (08) : 2201 - 2206
  • [25] Absence of the factor V Leiden mutation in Ethiopians
    Abdulkadir, J
    Feleke, Y
    Berg, JP
    Falch, JA
    Odegaard, OR
    THROMBOSIS RESEARCH, 1997, 86 (05) : 431 - 432
  • [26] How old is factor V Leiden mutation?
    Pawar, AR
    Shetty, S
    Ghosh, K
    Mohanty, D
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1591 - 1592
  • [27] Factor V Leiden and prothrombin gene mutation
    Björkman, A
    Svensson, PJ
    Hillarp, A
    Burtscher, IM
    Rünow, A
    Benoni, G
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (425) : 168 - 172
  • [28] Factor V Leiden gene mutation and preeclampsia?
    Thorp, JA
    Zucker, ML
    Plapp, FV
    Rachel, JM
    Hinkle, C
    JOURNAL OF MATERNAL-FETAL INVESTIGATION, 1997, 7 (01): : 19 - 20
  • [29] Factor V Leiden mutation and pregnancy complications
    Kjellberg, U.
    van Rooijen, M.
    Bremme, K.
    Hellgren, M.
    THROMBOSIS RESEARCH, 2009, 123 : S152 - S152
  • [30] The impact of the Factor V Leiden mutation on pregnancy
    Spina, V
    Aleandri, V
    Morini, F
    HUMAN REPRODUCTION UPDATE, 2000, 6 (03) : 301 - 306